BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

837 related articles for article (PubMed ID: 27045035)

  • 1. Murine Model for Preclinical Studies of Var2CSA-Mediated Pathology Associated with Malaria in Pregnancy.
    de Moraes LV; Dechavanne S; Sousa PM; Barateiro A; Cunha SF; Nunes-Silva S; Lima FA; Murillo O; Marinho CRF; Gangnard S; Srivastava A; Braks JA; Janse CJ; Gamain B; Franke-Fayard B; Penha-Gonçalves C
    Infect Immun; 2016 Jun; 84(6):1761-1774. PubMed ID: 27045035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel adenovirus encoded virus-like particles displaying the placental malaria associated VAR2CSA antigen.
    Andersson AC; Resende M; Salanti A; Nielsen MA; Holst PJ
    Vaccine; 2017 Feb; 35(8):1140-1147. PubMed ID: 28131394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chondroitin sulfate A-adhering Plasmodium falciparum-infected erythrocytes express functionally important antibody epitopes shared by multiple variants.
    Barfod L; Dobrilovic T; Magistrado P; Khunrae P; Viwami F; Bruun J; Dahlbäck M; Bernasconi NL; Fried M; John D; Duffy PE; Salanti A; Lanzavecchia A; Lim CT; Ndam NT; Higgins MK; Hviid L
    J Immunol; 2010 Dec; 185(12):7553-61. PubMed ID: 21078904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Id1-DBL2X of VAR2CSA as a key domain inducing highly inhibitory and cross-reactive antibodies.
    Bordbar B; Tuikue-Ndam N; Bigey P; Doritchamou J; Scherman D; Deloron P
    Vaccine; 2012 Feb; 30(7):1343-8. PubMed ID: 22226864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to Escherichia coli-expressed C-terminal domains of Plasmodium falciparum variant surface antigen 2-chondroitin sulfate A (VAR2CSA) inhibit binding of CSA-adherent parasites to placental tissue.
    Saveria T; Oleinikov AV; Wiliamson K; Chaturvedi R; Lograsso J; Keitany GJ; Fried M; Duffy P
    Infect Immun; 2013 Apr; 81(4):1031-9. PubMed ID: 23319559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential induction of functional IgG using the Plasmodium falciparum placental malaria vaccine candidate VAR2CSA.
    Pinto VV; Ditlev SB; Jensen KE; Resende M; Dahlbäck M; Andersen G; Andersen P; Theander TG; Salanti A; Nielsen MA
    PLoS One; 2011 Mar; 6(3):e17942. PubMed ID: 21464946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of VAR2CSA-deficient Plasmodium falciparum-infected erythrocytes selected for adhesion to the BeWo placental cell line.
    Yosaatmadja F; Andrews KT; Duffy MF; Brown GV; Beeson JG; Rogerson SJ
    Malar J; 2008 Mar; 7():51. PubMed ID: 18364051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chondroitin sulfate A-binding site of the VAR2CSA protein involves multiple N-terminal domains.
    Dahlbäck M; Jørgensen LM; Nielsen MA; Clausen TM; Ditlev SB; Resende M; Pinto VV; Arnot DE; Theander TG; Salanti A
    J Biol Chem; 2011 May; 286(18):15908-17. PubMed ID: 21398524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single full-length VAR2CSA ectodomain variant purifies broadly neutralizing antibodies against placental malaria isolates.
    Doritchamou JYA; Renn JP; Jenkins B; Mahamar A; Dicko A; Fried M; Duffy PE
    Elife; 2022 Feb; 11():. PubMed ID: 35103596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective Antibodies against Placental Malaria and Poor Outcomes during Pregnancy, Benin.
    Ndam NT; Denoeud-Ndam L; Doritchamou J; Viwami F; Salanti A; Nielsen MA; Fievet N; Massougbodji A; Luty AJ; Deloron P
    Emerg Infect Dis; 2015 May; 21(5):813-23. PubMed ID: 25898123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The NTS-DBL2X region of VAR2CSA induces cross-reactive antibodies that inhibit adhesion of several Plasmodium falciparum isolates to chondroitin sulfate A.
    Bigey P; Gnidehou S; Doritchamou J; Quiviger M; Viwami F; Couturier A; Salanti A; Nielsen MA; Scherman D; Deloron P; Tuikue Ndam N
    J Infect Dis; 2011 Oct; 204(7):1125-33. PubMed ID: 21881129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VAR2CSA signatures of high Plasmodium falciparum parasitemia in the placenta.
    Rovira-Vallbona E; Monteiro I; Bardají A; Serra-Casas E; Neafsey DE; Quelhas D; Valim C; Alonso P; Dobaño C; Ordi J; Menéndez C; Mayor A
    PLoS One; 2013; 8(7):e69753. PubMed ID: 23936092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VAR2CSA binding phenotype has ancient origin and arose before Plasmodium falciparum crossed to humans: implications in placental malaria vaccine design.
    Gangnard S; Chêne A; Dechavanne S; Srivastava A; Avril M; Smith JD; Gamain B
    Sci Rep; 2019 Nov; 9(1):16978. PubMed ID: 31740695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strain-transcendent immune response to recombinant Var2CSA DBL5-ε domain block P. falciparum adhesion to placenta-derived BeWo cells under flow conditions.
    Fernandez P; Petres S; Mécheri S; Gysin J; Scherf A
    PLoS One; 2010 Sep; 5(9):e12558. PubMed ID: 20838433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic differences and conservation among placental Plasmodium falciparum-infected erythrocytes and acquisition of variant-specific and cross-reactive antibodies.
    Beeson JG; Mann EJ; Byrne TJ; Caragounis A; Elliott SR; Brown GV; Rogerson SJ
    J Infect Dis; 2006 Mar; 193(5):721-30. PubMed ID: 16453269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of anti-VAR2CSA immunoglobulin G response in a cohort of senegalese pregnant women.
    Tuikue Ndam NG; Salanti A; Le-Hesran JY; Cottrell G; Fievet N; Turner L; Sow S; Dangou JM; Theander T; Deloron P
    J Infect Dis; 2006 Mar; 193(5):713-20. PubMed ID: 16453268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to a full-length VAR2CSA immunogen are broadly strain-transcendent but do not cross-inhibit different placental-type parasite isolates.
    Avril M; Hathaway MJ; Srivastava A; Dechavanne S; Hommel M; Beeson JG; Smith JD; Gamain B
    PLoS One; 2011 Feb; 6(2):e16622. PubMed ID: 21326877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of Duffy binding-like domains that bind chondroitin sulfate A and protection against pregnancy-associated malaria.
    Bir N; Yazdani SS; Avril M; Layez C; Gysin J; Chitnis CE
    Infect Immun; 2006 Oct; 74(10):5955-63. PubMed ID: 16988275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multilaboratory approach to preclinical evaluation of vaccine immunogens for placental malaria.
    Fried M; Avril M; Chaturvedi R; Fernandez P; Lograsso J; Narum D; Nielsen MA; Oleinikov AV; Resende M; Salanti A; Saveria T; Williamson K; Dicko A; Scherf A; Smith JD; Theander TG; Duffy PE
    Infect Immun; 2013 Feb; 81(2):487-95. PubMed ID: 23208604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequestration of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A, a receptor for maternal malaria: monoclonal antibodies against the native parasite ligand reveal pan-reactive epitopes in placental isolates.
    Lekana Douki JB; Traore B; Costa FT; Fusaï T; Pouvelle B; Sterkers Y; Scherf A; Gysin J
    Blood; 2002 Aug; 100(4):1478-83. PubMed ID: 12149234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.